Daligdig, Chantel .
HRN: 15-54-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/12/2023
02/17/2023
IVT
100mg
Od
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes